Recent news on Cardene

PDL BioPharma Announces First Quarter 2007 Financial Results  -  May 2, 2007
Earthtimes.org..."In the first quarter, our three marketed acute-care products, led by our Cardene(R) product, and our antibody platform royalties drove solid revenue growth

Cocozza’s walk-off HR makes Pemberton ill  -  May 1, 2007
phillyBurbs.com,Rancocas Valley 8, Burlington Twp. 3: Seth Cardene had three hits and Eric Hacker had two in the Red Devils' win. Cherokee 7, Shawnee 5: Dan Haverstick went

Fremont firm sues India's Sun over hypertension drug  -  Apr 20, 2007
Contra Costa Times,Fremont-based PDL BioPharma Inc. sued India's Sun Pharmaceutical Industries Ltd. to block a generic version of the hypertension drug Cardene.

Bordentown wins tournament  -  Apr 15, 2007
phillyBurbs.com,Seth Cardene and Eric Parker contributed doubles in the nonleague win. Lenape 4, Hopewell Valley 1: Jamie Moir tripled, struck out 11 and walked one in a

Holmwood top sectional awards at Champs  -  Apr 3, 2007
Jamaica Observer,Holmwood's Janeive Russell scored 23 points in Class Four - three more than teammate Osheen Erskine and Wolmer's Cardene Copeland, who won the Class Four

C'Bar, Holmwood top Champs  -  Apr 2, 2007
Jamaica Observer,Immaculate's Danielle Jeffrey in Class Two, Herbert Morrison Technical's Antonique Campbell in Class Three and Wolmer's Cardene Copeland in Class Four

5th straight title for rollicking Holmwood  -  Apr 1, 2007
Jamaica Observer,Immaculate's Danielle Jeffrey in Class 2, Herbert Morrison Technical's Antonique Campbell in Class 3 and Wolmer's Cardene Copeland in Class 4 completed the

Holmwood open 40-point lead  -  Mar 30, 2007
Jamaica Observer,Cardene Copeland of Wolmer's won the Class Four event in 12.11 seconds, ahead of Osheen Erskine of Holmwood and St Jago's Mellissa Williams (12.40 seconds).

Holmwood, C'bar eye Champs crown - ... Blake dethrones Rose in ...  -  Mar 30, 2007
Jamaica Gleaner,Jeffrey of Immaculate (11.64 - Class 2); Antonique Campbell of Herbert Morrison (11.89 - Class 3); Cardene Copeland of Wolmer's (12.11 - Class 4).

What Does Third Point See in PDL Biopharma?  -  Mar 23, 2007
Seeking Alpha,Loeb states that PDLI made "what we consider to be an ill-conceived purchase of ESP Pharma for $500M to gain access to products Cardene IV, Retavase and

Third Point Urges PDL BioPharma to Cut Costs  -  Mar 25, 2007
Drug Newswire (press release),Moreover, Cardene, which represents close to 60% of the combined $165M revenue stream from the three products, will go generic in 2009.

Firm optimistic with MS drug trials  -  Mar 14, 2007
Alameda Times-Star,Because one of the products, Cardene, represents close to 60 percent of the three products' combined revenue stream and will go generic in 2009,

PDL BioPharma Announces Fourth Quarter and Full Year 2006 ...  -  Feb 21, 2007
Earthtimes.orgResults for the 2005 period included approximately nine months of sales since the company began marketing Cardene(R) IV, Retavase and IV Busulfex(R)

SCCM: Clevidipine Seems Safe and Effective in BP Control  -  Feb 20, 2007
MedPage Today,A better comparison, he said, would be intravenous nicardipine (Cardene IV), a second-generation calcium channel blocker that is also in wide use and is

Real estate transactions  -  Feb 16, 2007
St. Petersburg Times,10003 86th Way N, to Bradley J. & Roberta A. Gourdoux by Thomas B. & Lillian F. Cardene, $242500, 01/03/2007. 10091 85th St., to Tom Gerald Benner by

Indy lawmaker to head conference  -  Jan 30, 2007
Indiana Statesman,Cardene Mays, a state representative from Indianapolis and the owner of the Indianapolis Recorder, a black newspaper in Indianapolis.

ACNP: Hypertension Drugs May Block Alzheimer's  -  Dec 6, 2006
Psychiatric Times,Dr. Pasinetti presented data on three of the drugs -- propranolol (sold under various brand names), Cardene (nicardapine), and Cozaar (losartan) -- that

PDL BioPharma Q3 2006 Earnings Call Transcript  Nov 3, 2006
...of Retavase in the current quarter and in 2006 in general, the product continues to diversify our portfolio while enabling sales of Cardene in certain customer ... -Seeking Alpha, PDL BioPharma Announces Third Quarter 2006 Financial Results  Nov 2, 2006
..."During the third quarter, increases in Cardene IV sales and strong partner-driven royalties continued to propel our underlying revenue growth," PDL BioPharma ... -Earthtimes.org PDL's Sales Top Estimates  Nov 2, 2006
Overall product sales were $41.1 million, including $28.7 million in sales of the blood pressure drug Cardene, a year-over-year increase of 34%. ... -TheStreet.com PDL BioPharma Trims 3Q Loss  Nov 2, 2006
...with Roche on daclizumab for asthma. Strong sales of Cardene IV and royalties also drove revenue. The company refined its full-year ... -MSN Money PolyMedix Appoints Vice President of Clinical Development  Nov 8, 2006
Dr. McAllister has worked on the development of such major pharmaceutical products as Lupron, Pravachol, Capoten, Kerlone, Cardene, Calan, Avandia, Actos ... -PharmaLive.com (press release), Needham Starts PDL BioPharma (PDLI) at Buy  Oct 12, 2006
We expect that the current growth drivers of marketed products such as Cardene, royalty streams from antibody sales of brand name products such as Avastin and ... -StreetInsider.com (subscription), Medicines updates clinical study  Sep 11, 2006
...of clevidipine to a trio of current blood pressure therapies: nitroglycerin, sodium nitroprusside and nicardipine, a Roche drug marketed under the name Cardene ... -Newark Star Ledger

PDL Biopharma: Troubled Summer, But Holding On  Sep 13, 2006
The biggest of these is Cardene IV for hypertension, and they've also bought the rights to oral Cardene to strengthen their position. ... -Seeking Alpha

Roche Gives Up Daclizumab; PDL Seeking Asthma Partner  -  Nov 22, 2006
BioWorld Online,PDL gained Cardene in its 2005 acquisition of Edison, NJ-based ESP Pharma Inc., in a deal valued at $475 million. ESP got the drug from Wyeth

ACNP: Hypertension Drugs May Block Alzheimer's  -  Dec 6, 2006
Psychiatric Times,Dr. Pasinetti presented data on three of the drugs -- propranolol (sold under various brand names), Cardene (nicardapine), and Cozaar (losartan) -- that

PDL Just Got Riskier  Aug 8, 2006
...ago, but that figure included adjustments. The hypertension drug Cardene IV saw its sales rise 47%. PDL earned 17 cents a share ... -TheStreet.com

PDL BioPharma Announces Second Quarter 2006 Financial Results  Aug 3, 2006
Net product sales in the second quarter of 2006, which were comprised solely of Cardene IV, Retavase ... Cardene is a registered trademark of Hoffmann-La Roche. ... -Yahoo! News

Supporting Corps D’Esprit  Aug 5, 2006
For example, when Mr. Spitznagel started ESP Pharma in 2002, he acquired the rights to just one drug, injectable blood pressure formula Cardene IV, which he ... -Red Herring

PDL BioPharma loss widens, trial fails endpoint  Aug 3, 2006
Second-quarter net sales of its three biopharmaceutical products -- Cardene IV, used to reduce high blood pressure during or after surgery; heart treatment ... -MarketWatch

PDL Looks for a Push  Aug 2, 2006
...for PDL. For PDL is to impress investors it will have to be through its own drugs, such as Cardene, Retavase and Busulfex. The latter ... -TheStreet.com

Local scenes for July 9  Jul 9, 2006
Gabby Pfeiffer, Spracklin and Kayla Cardene combined for a no-hitter and struck out nine as Sacred Heart blanked Willingboro, 24-0. Rachel Simodejka (four RBIs ... -phillyBurbs.com



PDL's Recent Slump Seen Overly Exaggerated  May 9, 2006
...he said. "Most notably, Cardene IV loses patent protection in November 2009, and the US Queen patents expire in 2014.". The Queen ... - Forbes

PDL BioPharma Announces First Quarter 2006 Financial Results  May 2, 2006
Net sales of Cardene(R) IV, Retavase(R) and IV Busulfex(R) for the 2006 first quarter totaled $35.7 million, while net sales of four off-patent branded ... - MSN Money

A DIFFERENT KIND OF ANGINA  May 7, 2006
...treatment. So are drugs called calcium channel blockers. Some brand names are Cardizem, Procardia, Cardene, Plendil and Norvasc. The ... - Charlotte Sun-Herald

Martinson, Florence getting better with each game  Apr 20, 2006
Seth Cardene cut the Florence lead to 3-1 with an RBI ground out that plated Jarrett Barnes. Martinson got Kevin Rogers to pop out to end the threat. ... - phillyBurbs.com

Giambrone's hit lifts Florence over Delran  Apr 19, 2006
...come-from-behind win. Seth Cardene doubled in the seventh and scored the game-tying run on Ryan Leeds' single. New Egypt 10, Burlington ... - phillyBurbs.com





Drug company sees red despite gains Half of revenue comes from ...  10 Apr 2006
The purchase helped boost revenue by giving PDL three commercial products: blood pressure drug Cardene IV; post-heart attack drug Retavase; and IV Busulfex ... - Contra Costa Times

Cardene helps RV down Township  Apr 7, 2006
For just a second — one pitch, actually — Rancocas Valley High School's Seth Cardene looked like a sophomore playing his first varsity game. ... - phillyBurbs.com

PDL BioPharma Announces Fourth Quarter and Full Year 2005 ...  Feb 27, 2006
...fourth quarter and full year, reflect a growing commercial presence in the acute-care hospital market with three proprietary marketed products in Cardene(R) IV ... - PharmaLive.com,

PDL's Potent Pick-Me-Up  Feb 27, 2006
BIOTECH NEWCOMERS. Cardene IV is approved for the short-term treatment of hypertension when oral therapy is not feasible or desirable. ... - BusinessWeek

Protein Design Labs Becomes PDL BioPharma  Jan 9, 2006
The company now markets Cardene(R) IV (nicardipine hydrochloride) for short-term treatment of hypertension when oral therapy is not feasible or desirable ... - MSN Money

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional